Natural History of Pain After Shoulder Arthroplasty Conducted With Multimodal Analgesia
TSA
1 other identifier
observational
108
1 country
1
Brief Summary
This study aims to identify the timeline of pain following total shoulder replacement with the goal of developing data for a subsequent randomized trial. The investigators believe that with using HSS's current protocol, many patients have postoperative pain that is no worse than their preoperative pain. Previous HSS anesthesia protocols for total shoulder arthroplasty patients have not formally followed patients past their hospital discharge, and the investigators believe that some patients do experience moderate to severe subacute postoperative pain. Therefore, this study's primary outcome is to look at the numeric pain scores at 14 days after surgery. Future studies will look at measures of preventing bruising and subsequent pain after shoulder replacement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 3, 2017
CompletedFirst Posted
Study publicly available on registry
January 13, 2017
CompletedStudy Start
First participant enrolled
January 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 22, 2018
CompletedResults Posted
Study results publicly available
March 4, 2025
CompletedMarch 4, 2025
January 1, 2025
11 months
January 3, 2017
April 19, 2022
February 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Numeric Rating Scale Pain Scores at Post-operative Day 14
Quantifying patients' pain at a sub-acute time point after surgery at rest and with movement. The numeric rating scale (NRS) is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable".
14 days after surgery for each patient
Secondary Outcomes (9)
Numeric Rating Scale (NRS) Pain With Movement and at Rest.
Days 1 day (POD0), 3 days(POD3), 7 days(POD7) and 3 months(POD90) after surgery
Opioid Consumption (in Past 24 Hours)
Days 1 day, 3 days, 7 days after surgery
Opioid Related Symptom Distress Scale
Day 1 after surgery
Range of Motion
Day 14 after surgery and 3 months after surgery
Severity of Bruising
Day 14 after surgery
- +4 more secondary outcomes
Interventions
The study is just using validated surveys to assess pain and mood states after surgery
Eligibility Criteria
Patients undergoing TSA for Osteoarthritis, Reverse, Anatomic procedures
You may qualify if:
- All patients eligible for the standardized anesthetic for TSA
- Patients who are capable to provide informed consent and answer questions in English (Study involves questionnaires validated in English)
- Age 18-80
You may not qualify if:
- Incapable to provide informed consent
- Contraindications for regional anesthesia (anticoagulation, infection at injection site)
- Patients undergoing TSA for Trauma or Rheumatoid Arthritis
- Conversion of hemiarthroplasty to TSA
- Planned use of tranexamic acid
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital for Special Surgery
New York, New York, 10021, United States
Related Publications (2)
Goon AK, Dines DM, Craig EV, Gordon MA, Goytizolo EA, Lin Y, Lin E, YaDeau JT. A clinical pathway for total shoulder arthroplasty-a pilot study. HSS J. 2014 Jul;10(2):100-6. doi: 10.1007/s11420-014-9381-0. Epub 2014 Mar 8.
PMID: 25050091BACKGROUNDYaDeau JT, Gordon MA, Goytizolo EA, Lin Y, Fields KG, Goon AK, Holck G, Miu TW, Gulotta LV, Dines DM, Craig EV. Buprenorphine, Clonidine, Dexamethasone, and Ropivacaine for Interscalene Nerve Blockade: A Prospective, Randomized, Blinded, Ropivacaine Dose-Response Study. Pain Med. 2016 May;17(5):940-60. doi: 10.1093/pm/pnv010. Epub 2015 Dec 14.
PMID: 26814246BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Jacques Yadeau
- Organization
- Hospital for Special Surgery, Anesthesiology
Study Officials
- PRINCIPAL INVESTIGATOR
Jacques YaDeau, MD, PhD
Hospital for Special Surgery, New York
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 3, 2017
First Posted
January 13, 2017
Study Start
January 27, 2017
Primary Completion
December 18, 2017
Study Completion
March 22, 2018
Last Updated
March 4, 2025
Results First Posted
March 4, 2025
Record last verified: 2025-01